Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023

BUY
$351.71 - $456.01 $365,778 - $474,250
1,040 Added 2363.64%
1,084 $427,000
Q3 2022

Oct 27, 2022

SELL
$412.59 - $563.26 $1.05 Million - $1.43 Million
-2,540 Reduced 98.3%
44 $19,000
Q1 2022

May 16, 2022

SELL
$524.57 - $735.42 $758,003 - $1.06 Million
-1,445 Reduced 35.86%
2,584 $1.46 Million
Q4 2021

Feb 10, 2022

BUY
$708.84 - $794.68 $2.86 Million - $3.2 Million
4,029 New
4,029 $3.04 Million
Q1 2020

May 13, 2020

SELL
$320.01 - $409.07 $812,825 - $1.04 Million
-2,540 Closed
0 $0
Q4 2019

Feb 10, 2020

BUY
$319.73 - $374.2 $812,114 - $950,468
2,540 New
2,540 $940,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.48B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Achmea Investment Management B.V. Portfolio

Follow Achmea Investment Management B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Achmea Investment Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Achmea Investment Management B.V. with notifications on news.